Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
DromosPTM is a Patient Therapy Management SaaS platform for specialty pharmacies, developed by the clinical pharmacist team at Pharmacy Advantage. Its core goal is to bring prior authorizations, patient counseling, refills, financial assistance, manufacturer reporting, and operational metrics into a unified workflow. It is closer to a vertical pharmacy operations and clinical services platform than a general-purpose CRM or ticketing system.
The product focuses on “queue-based workflows”: configurable work queues, tag-based processes, and forms help structure the large number of data points required for prior authorizations. The patient counseling module can record therapy, adherence, follow-ups, and outcomes. The financial assistance module is used to track copay support from foundations or nonprofit organizations. E-faxing is embedded into the workflow to reduce offline communication gaps. Team dashboards provide real-time visibility into workload and productivity, and can automatically filter by disease state to help supervisors allocate resources. For access control, the website explicitly mentions personalized user roles and granular permissions, allowing organizations to control which features employees can view and operate.
DromosPTM is already integrated with McKesson EnterpriseRx for data exchange, and says it can be adapted to most pharmacy dispensing software. Its patient portal is also integrated with EnterpriseRx, supporting patient refills, address and phone updates, and refill status checks. The physician portal and EMR health data integration are still marked as in development. Deployment is cloud-based SaaS, hosted on AWS and accessible via browser. Security and compliance disclosures are fairly limited, mentioning only secure internet connectivity and AWS. Although user reviews say it can help with specialty pharmacy accreditations such as URAC, ACHC, and VIPPS, there is no clear information found on certifications such as HIPAA or SOC 2.
The official website does not publish plans, pricing, implementation fees, or contract terms, and only offers demo requests. Its strengths are its focused use case, complete workflow coverage, and strong reporting capabilities, making it especially suitable for pharmacies that need to submit limited-distribution drug reports to manufacturers, pursue accreditation, and improve prior authorization efficiency. The main drawbacks are limited purchasing transparency and undisclosed API/developer support. If an organization already has complex HIS, EMR, or on-premise pharmacy systems, integration costs need to be assessed separately.
It is best suited for U.S. specialty pharmacies, hospital pharmacies, and retail pharmacy teams managing complex therapies and medications for chronic or rare diseases. For users in China, the official website does not disclose information about access, payment methods, or local compliance adaptation, so access status is considered unknown. At the same time, the product is deeply tied to the U.S. pharmacy, insurance, manufacturer limited-distribution, and accreditation ecosystem. Any domestic deployment would need to prioritize evaluation of alternatives for medical insurance, prescription circulation, pharmacy systems, and data compliance.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on dromosrx.com official site.
dromosrx.com is an United States Health provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach dromosrx.com directly.